Clinical Trial Update: Bone Status on Patients With Genetic Hemochromatosis: a 3 Years Descriptive and Evolutionary Study

View source ↗

Summary

This is a completed three-year descriptive and evolutionary study assessing bone status in patients with hereditary hemochromatosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Hemochromatosis

Snippet

Sponsor: Rennes University Hospital | Conditions: Genetic Hemochromatosis | Status: COMPLETED